Ari Gilad Mandler

Ari Gilad Mandler

Auto-generated profile, based on publicly available information

Ari Gilad Mandler

Department of Medicine, Division of Cardiology, Weill Cornell Medicine—New York Presbyterian Hospital and Weill Cornell Cardiovascular Outcomes Research Group (CORG) , 520 East 70th Street 4th Floor, New York, NY 10021

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Journal of Digital Imaging
Verified
Journal Article
Closed access
PDF file
AMAri Gilad Mandler
Ari Gilad Mandler

26 December 2024 in EP Europace
Verified
Journal Article
Open access
AMAri G Mandler
Ari G Mandler
CSChristopher T Sciria
Christopher T Sciria
EKEdward V Kogan
Edward V Kogan
IKIlya Kim
Ilya Kim
IYIlhwan Yeo
Ilhwan Yeo
JCJim W Cheung
Jim W Cheung
Aims: Utilization of transvenous lead extraction/removal (TLE) for the management of cardiac implantable electronic device (CIED)-associated infective endocarditis (IE) remains low. The aim of this study was to examine the impact of hospital TLE procedural volume on TLE utilization and outcomes for patients with CIED-associated IE. Methods and results: Using the Nationwide Readmissions Database, we evaluated 21 545 admissions for patients (mean age 70 years, 39% female) with CIEDs hospitalized with IE at TLE centres. Hospitals were categorized based on annual volume tertiles: (i) low-volume (1–17 TLEs/year), (ii) medium-volume (18–45 TLEs/year), and (iii) high-volume centres (>45 TLEs/year). Between 2016 and 2019, 57% of admissions in the study were to low-volume TLE centres. Transvenous lead extraction/removal was performed during 6.9, 19.3, and 26% of admissions for CIED-associated IE at low-, medium-, and high-volume TLE centres, respectively (P < 0.001). After adjustment for age and comorbidities, hospitalization for IE at high-volume centres was independently associated with TLE when compared with low-volume centres (adjusted odds ratio 4.26; 95% confidence interval 3.53–5.15). Transvenous lead extraction/removal-associated complication rates were similar at 2.5, 2.3, and 3.4% at low-, medium-, and high-volume centres, respectively (P = 0.493). Overall inpatient mortality during admissions to low-, medium-, and high-volume centres was also similar. Conclusion: Admissions to high-volume TLE centres were associated with higher utilization of TLE for management of CIED-associated IE. Transvenous lead extraction/removal-associated complications and mortality among patients hospitalized with CIED-associated IE were similar when stratified by hospital TLE volume, but this needs to be considered in context of significant differences in patient comorbidity burden between centres.

22 June 2019 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
RLRobert J Lewis
Robert J Lewis
AMAri G Mandler
Ari G Mandler
GPGeovanny Perez
Geovanny Perez
PMPamela A Mudd
Pamela A Mudd
We report a significant complication after tracheocutaneous fistula (TCF) excision with closure by secondary intention in a 4-year-old boy who had been tracheostomy dependent since infancy. He had a persistent 3 mm TCF one year after decannulation. On postoperative day 2 the patient developed profound subcutaneous emphysema and pneumomediastinum. He was extubated after 2 days and discharged from the hospital on postoperative day 7. At follow up he had complete resolution of subcutaneous emphysema and complete closure of the TCF. The main methods of TCF closure and management of subcutaneous emphysema are discussed along with the lessons learned from this case.

1 June 2020 in Journal Of Hypertension
Verified
Journal Article
Closed access
AMAri G. Mandler
Ari G. Mandler
AGAri G.
Ari G.